Table 2.
Tumor-node-metastasis stage and clinical type of the study population n (%)
| Variable | Total patients (n = 375) | HCC patients with diabetes (n = 63) | HCC patients without diabetes (n = 312) | P value |
| T stage | ||||
| T1 | 82 (21.9) | 15 (23.8) | 67 (21.5) | 0.683 |
| T2 | 90 (24.0) | 19 (30.2) | 71 (22.8) | 0.210 |
| T3a | 157 (41.9) | 22 (34.9) | 135 (43.3) | 0.221 |
| T3b | 37 (9.9) | 6 (9.5) | 31 (9.9) | 0.920 |
| T4 | 9 (2.4) | 1 (1.6) | 8 (2.6) | 0.991 |
| N stage | ||||
| N0 | 334 (89.1) | 57 (90.5) | 277 (88.8) | 0.694 |
| N1 | 41 (10.9) | 6 (9.5) | 35 (11.2) | - |
| M stage | ||||
| M0 | 269 (71.7) | 49 (77.8) | 220 (70.5) | 0.243 |
| M1 | 106 (28.3) | 14 (22.2) | 92 (29.5) | - |
| Clinical classification | ||||
| Massive | 213 (56.8) | 29 (46.0) | 184 (59.0) | 0.059 |
| Nodular | 117 (31.2) | 22 (34.9) | 95 (30.4) | 0.485 |
| Small-cancer | 28 (7.5) | 8 (12.7) | 20 (6.4) | 0.142 |
| Diffuse | 17 (4.5) | 4 (6.3) | 13 (4.2) | 0.503 |
HCC: Hepatocellular carcinoma; T: Tumor; N: Node; M: Metastasis.